Skip Navigation

Annals of Oncology 2004 15(10):1574; doi:10.1093/annonc/mdh396
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Utkan, G.
Right arrow Articles by Yalçyn, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Utkan, G.
Right arrow Articles by Yalçyn, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 European Society for Medical Oncology

The efficacy and safety of oral ibandronate in the treatment of metastatic bone disease in patients with breast cancer

The first 10% of the full text of this article appears below.

We read with interest D. Tripathy and coworkers’ study [1Go], published in the May 2004 issue of Annals . . . [Full Text of this Article]

G. Utkan*, A. Büyükçelik and B. Yalçyn

Department of Medical Oncology, Ankara University School of Medicine, Ibni Sina Hospital, Ankara, Turkey

* Email: gungorutkan_md@yahoo.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?